Health

Nucleus Genomics Expands ‘Optimization’ Embryo Testing to India, Middle East

A liquid solution in a laboratory for in vitro fertilization.Photographer: Kostas Tsironis/Bloomberg

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Gerry Smith

March 26, 2026 at 1:00 PM UTC

A New York-based embryo testing startup has struck deals with IVF clinics in India and the Middle East to expand use of the controversial technology.

Nucleus Genomics Inc. has agreements with Indira IVF, which runs more than 165 fertility clinics across India, and Abu Ghosh Fertility Group, which operates in Saudi Arabia and Jordan, the company said Thursday. As part of the deals, the clinics will offer Nucleus’ tests to couples undergoing in vitro fertilization. Nucleus also has an existing partnership with an operator of IVF clinics in Mexico.